fda ban tirzepatide compounded legal is IT'S PROTECTING PATIENTS': A Kentucky lawmaker has filed a new bill that would on Compounded GLP-1 – FDA says years-long tirzepatide shortage

According to the Navadhi Global Peptide Therapy Market Strategic Research Report 2026-2031 , India's emergence as both a high-growth demand market (19.89% CAGR) and a biosimilar manufacturing hub creates a unique dual role as GLP-1 costs decline through Indian biosimilar production, the addressable patient population in price-sensitive Asian and African markets will expand dramatically, driving the 21.24% volume CAGR through 2031.

Alli (orlistat) capsules, for oral use

This is the most common pattern in dermatology editorial guidance

I knowthats probably not what you were hoping to hear

The slowed gastric emptying may increase pressure within the stomach, potentially exacerbating reflux in susceptible individuals